PT1225890E - Rivastigmina para o tratamento de doencas oculares - Google Patents

Rivastigmina para o tratamento de doencas oculares

Info

Publication number
PT1225890E
PT1225890E PT00992430T PT00992430T PT1225890E PT 1225890 E PT1225890 E PT 1225890E PT 00992430 T PT00992430 T PT 00992430T PT 00992430 T PT00992430 T PT 00992430T PT 1225890 E PT1225890 E PT 1225890E
Authority
PT
Portugal
Prior art keywords
rivastigmine
treatment
eye diseases
diseases
eye
Prior art date
Application number
PT00992430T
Other languages
English (en)
Inventor
David Goldblum
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1225890E publication Critical patent/PT1225890E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
PT00992430T 1999-10-19 2000-10-17 Rivastigmina para o tratamento de doencas oculares PT1225890E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99120678 1999-10-19

Publications (1)

Publication Number Publication Date
PT1225890E true PT1225890E (pt) 2005-05-31

Family

ID=8239225

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00992430T PT1225890E (pt) 1999-10-19 2000-10-17 Rivastigmina para o tratamento de doencas oculares

Country Status (13)

Country Link
US (2) US6534541B1 (pt)
EP (1) EP1225890B1 (pt)
JP (1) JP2003512324A (pt)
AR (1) AR026062A1 (pt)
AT (1) ATE285764T1 (pt)
AU (1) AU766001B2 (pt)
CA (1) CA2384690C (pt)
DE (1) DE60017174T2 (pt)
DK (1) DK1225890T3 (pt)
ES (1) ES2234708T3 (pt)
NZ (1) NZ518164A (pt)
PT (1) PT1225890E (pt)
WO (1) WO2001028553A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141762A0 (en) 1998-10-01 2002-03-10 Novartis Ag New oral formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
CN107417574B (zh) * 2017-03-21 2019-12-03 浙江省医学科学院 2,4-双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
WO1993005779A1 (en) 1991-09-26 1993-04-01 The United States Of America Represented By The Secretary Department Of Health And Human Services Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
DE69233093T2 (de) 1991-09-26 2003-12-18 Us Gov Health & Human Serv Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure

Also Published As

Publication number Publication date
US20030119832A1 (en) 2003-06-26
AU2834901A (en) 2001-04-30
NZ518164A (en) 2003-10-31
US6835748B2 (en) 2004-12-28
US6534541B1 (en) 2003-03-18
AU766001B2 (en) 2003-10-09
ATE285764T1 (de) 2005-01-15
AR026062A1 (es) 2002-12-26
WO2001028553A1 (en) 2001-04-26
CA2384690A1 (en) 2001-04-26
ES2234708T3 (es) 2005-07-01
CA2384690C (en) 2010-08-17
DE60017174T2 (de) 2005-12-22
EP1225890A1 (en) 2002-07-31
EP1225890B1 (en) 2004-12-29
JP2003512324A (ja) 2003-04-02
DE60017174D1 (de) 2005-02-03
DK1225890T3 (da) 2005-04-04

Similar Documents

Publication Publication Date Title
EE9900469A (et) Sulfoonamiidid endoteliini vahendatud haiguste raviks
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
PT1223927E (pt) Utilizacao de retigabina para o tratamento de dores neuropaticas
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
IL196301A0 (en) Medicament for the treatment of hapatitis c
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
FI20000863A (fi) Uusi hoitomenetelmä
PT1206436E (pt) Retinoides para o tratamento de enfisema
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
PT1321135E (pt) Composicao para o tigimento de oxidacao das fibras ceratinicas
NO20005179D0 (no) Medikament behandling
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
NO20033804L (no) Karbamatforbindelser for behandling av smerte
HUP0104963A3 (en) Compositions for the treatment of skin diseases
PT1286986E (pt) Derivados de quinolil-piperidin-4-ilideno-metil-benzamida para o tratamento da dor
PT1225890E (pt) Rivastigmina para o tratamento de doencas oculares
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
PT1135134E (pt) Utilizacao de estimuladores do factor neurotrofico para o tratamento de doencas oftalmicas neurodegenerativas
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer